Recently, we have shown that in advanced prostate cancer cells, giantin is present primarily as a monomer due to downregulation of protein disulfide isomerase A3 (PDIA3), also known as ERp57, the enzyme that catalyzes giantin dimerization8. This evidence concerns the gene PDIA3 and prostate cancer.